Showing results (1161-1170 of 2,231) with videos related to
Sort By:
Pageof 224
Cancer Biotherapy & Radiopharmaceuticals|June 10, 2004
Radioimmunotherapy of human colon carcinoma xenografts using a 213Bi-labeled domain-deleted humanized monoclonal antibodyDiane Milenic, Kayhan Garmestani, Ekaterina Dadachova, et al.Cancer Biotherapy & Radiopharmaceuticals|June 10, 2004
PET radioimmunoscintigraphy of renal cell cancer using 89Zr-labeled cG250 monoclonal antibody in nude ratsAdrienne Brouwers, Iris Verel, Julliëtte Van Eerd, et al.Cancer Biotherapy & Radiopharmaceuticals|June 10, 2004
Radiolabeled RGD-DTPA-Tyr3-octreotate for receptor-targeted radionuclide therapyBert Bernard, Astrid Capello, Martin van Hagen, et al.Cancer Biotherapy & Radiopharmaceuticals|June 10, 2004
99mTc-EDDA/HYNIC-TOC in the management of medullary thyroid carcinomaMaria Parisella, Calogero D'Alessandria, Bieke van de Bossche, et al.Cancer Biotherapy & Radiopharmaceuticals|June 10, 2004
99mTc-depreotide scintigraphy in the evaluation of indeterminate pulmonary lesions: clinical experienceTeresa Martins, José Sena Lino, Sância Ramos, et al.Cancer Biotherapy & Radiopharmaceuticals|August 3, 2004
Rationale for sentinel node biopsy to stage N0 head and neck squamous-cell carcinomaGary RossCancer Biotherapy & Radiopharmaceuticals|April 8, 2004
Fusion imaging in nuclear medicine--applications of dual-modality systems in oncologyOrazio Schillaci, Giovanni SimonettiCancer Biotherapy & Radiopharmaceuticals|April 8, 2004
Evaluation of a cathepsin-cleavable peptide linked radioimmunoconjugate of a panadenocarcinoma MAb, m170, in mice and patientsGerald L DeNardo, Sally J DeNardoCancer Biotherapy & Radiopharmaceuticals|March 22, 2005
Population biokinetic modeling of thyroid uptake and retention of radioiodineJohan Areberg, H Jönsson, S MattssonCancer Biotherapy & Radiopharmaceuticals|March 22, 2005
The role of 99mTc-tetrofosmin scintigraphy for staging patients with laryngeal cancerBruno Fattori, Mariano Grosso, Andrea Nacci, et al.Pageof 224